Outcome measures in studies on the use of oxytocin for the treatment of delay in labour: A systematic review.

Hdl Handle:
http://hdl.handle.net/10147/323875
Title:
Outcome measures in studies on the use of oxytocin for the treatment of delay in labour: A systematic review.
Authors:
Begley, Cecily M; Gross, Mechthild M; Dencker, Anna; Benstoem, Carina; Berg, Marie; Devane, Declan
Affiliation:
School of Nursing and Midwifery, Trinity College Dublin, 24 D׳Olier St, Dublin 2, Ireland. Electronic address: cbegley@tcd.ie.
Citation:
Outcome measures in studies on the use of oxytocin for the treatment of delay in labour: A systematic review. 2014: Midwifery
Journal:
Midwifery
Issue Date:
1-Jul-2014
URI:
http://hdl.handle.net/10147/323875
DOI:
10.1016/j.midw.2014.06.005
PubMed ID:
25017174
Additional Links:
http://www.sciencedirect.com/science/article/pii/S0266613814001739
Abstract:
to identify primary and secondary outcome measures in randomised trials, and systematic reviews of randomised trials, measuring effectiveness of oxytocin for treatment of delay in the first and second stages of labour, and to identify any positive health-focussed outcomes used.; eight relevant citation databases were searched up to January 2013 for all randomised trials, and systematic reviews of randomised trials, measuring effectiveness of oxytocin for treatment of delay in labour. Trials of active management of labour or partogram action lines were excluded. 1918 citations were identified. Two reviewers reviewed all citations and extracted data. Twenty-six individual trials and five systematic reviews were included. Primary and secondary outcome measures were documented and analysed using frequency distributions.; most frequent primary outcomes were caesarean section (n=15, 46%), length of labour (n=14, 42%), measurements of uterine activity (n=13, 39%) and mode of vaginal birth (n=9, 27%). Maternal satisfaction was identified a priori by one review and included as a secondary outcome by three papers. No further positive health-focussed outcomes were identified.; outcomes used to measure the effectiveness of oxytocin for treatment of delay in labour are heterogeneous and tend to focus on adverse events.; it is recommended that, in future randomised trials of oxytocin use for delay in labour, some women-centred and health-focussed outcome measures should be used, which may instil a more salutogenic culture in childbirth.
Item Type:
Article
Language:
en
Keywords:
PREGNANCY; PREGNANT WOMEN; MIDWIFE
Local subject classification:
OXYTOCIN; LABOUR
ISSN:
1532-3099
Sponsors:
Funder: This paper is part of the work of EU COST Action IS0907: ‘Childbirth Cultures,Concerns,and Consequences:Creating a dynamic EU framework for optimal maternity care’ and was supported by the European Commission under EU COST Action IS0907.

Full metadata record

DC FieldValue Language
dc.contributor.authorBegley, Cecily Men_GB
dc.contributor.authorGross, Mechthild Men_GB
dc.contributor.authorDencker, Annaen_GB
dc.contributor.authorBenstoem, Carinaen_GB
dc.contributor.authorBerg, Marieen_GB
dc.contributor.authorDevane, Declanen_GB
dc.date.accessioned2014-07-29T11:13:32Z-
dc.date.available2014-07-29T11:13:32Z-
dc.date.issued2014-07-01-
dc.identifier.citationOutcome measures in studies on the use of oxytocin for the treatment of delay in labour: A systematic review. 2014: Midwiferyen_GB
dc.identifier.issn1532-3099-
dc.identifier.pmid25017174-
dc.identifier.doi10.1016/j.midw.2014.06.005-
dc.identifier.urihttp://hdl.handle.net/10147/323875-
dc.description.abstractto identify primary and secondary outcome measures in randomised trials, and systematic reviews of randomised trials, measuring effectiveness of oxytocin for treatment of delay in the first and second stages of labour, and to identify any positive health-focussed outcomes used.-
dc.description.abstracteight relevant citation databases were searched up to January 2013 for all randomised trials, and systematic reviews of randomised trials, measuring effectiveness of oxytocin for treatment of delay in labour. Trials of active management of labour or partogram action lines were excluded. 1918 citations were identified. Two reviewers reviewed all citations and extracted data. Twenty-six individual trials and five systematic reviews were included. Primary and secondary outcome measures were documented and analysed using frequency distributions.-
dc.description.abstractmost frequent primary outcomes were caesarean section (n=15, 46%), length of labour (n=14, 42%), measurements of uterine activity (n=13, 39%) and mode of vaginal birth (n=9, 27%). Maternal satisfaction was identified a priori by one review and included as a secondary outcome by three papers. No further positive health-focussed outcomes were identified.-
dc.description.abstractoutcomes used to measure the effectiveness of oxytocin for treatment of delay in labour are heterogeneous and tend to focus on adverse events.-
dc.description.abstractit is recommended that, in future randomised trials of oxytocin use for delay in labour, some women-centred and health-focussed outcome measures should be used, which may instil a more salutogenic culture in childbirth.-
dc.description.sponsorshipFunder: This paper is part of the work of EU COST Action IS0907: ‘Childbirth Cultures,Concerns,and Consequences:Creating a dynamic EU framework for optimal maternity care’ and was supported by the European Commission under EU COST Action IS0907.en_GB
dc.languageENG-
dc.language.isoenen
dc.relation.urlhttp://www.sciencedirect.com/science/article/pii/S0266613814001739en_GB
dc.rightsArchived with thanks to Midwiferyen_GB
dc.subjectPREGNANCYen_GB
dc.subjectPREGNANT WOMENen_GB
dc.subjectMIDWIFEen_GB
dc.subject.otherOXYTOCINen_GB
dc.subject.otherLABOURen_GB
dc.titleOutcome measures in studies on the use of oxytocin for the treatment of delay in labour: A systematic review.en_GB
dc.typeArticleen
dc.contributor.departmentSchool of Nursing and Midwifery, Trinity College Dublin, 24 D׳Olier St, Dublin 2, Ireland. Electronic address: cbegley@tcd.ie.en_GB
dc.identifier.journalMidwiferyen_GB

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.